Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
493
Frequently Asked Questions
What is Market Cap of Immunocore Holdings plc - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Immunocore Holdings plc - ADR market cap is $1.78B.
What is the 52-week high for Immunocore Holdings plc - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Immunocore Holdings plc - ADR 52 week high is $39.33 as of September 15, 2025.
What is the 52-week low for Immunocore Holdings plc - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Immunocore Holdings plc - ADR 52 week low is $23.15 as of September 15, 2025.
What is Immunocore Holdings plc - ADR stock price today?
Immunocore Holdings plc - ADR stock price today is $34.43.
What was Immunocore Holdings plc - ADR stock price yesterday?
Immunocore Holdings plc - ADR stock price yesterday was $35.24.
What is the PE ratio of Immunocore Holdings plc - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Immunocore Holdings plc - ADR’s P/E ratio is -85.20.
What is the Price-to-Book ratio of Immunocore Holdings plc - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Immunocore Holdings plc - ADR P/B ratio is 4.5956.
What is the 50-day moving average of Immunocore Holdings plc - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Immunocore Holdings plc - ADR 50-day moving average is $34.01.
How many employess does Immunocore Holdings plc - ADR has?